skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Imagens remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Optic chiasm involvement in ms, aquaporin-4 antibody-positive nmosd, and mog antibody-associated disease
Optic chiasm involvement in ms, aquaporin-4 antibody-positive nmosd, and mog antibody-associated disease
Material Type:
Imagem 		Adicionar ao Meu Espaço

Optic chiasm involvement in ms, aquaporin-4 antibody-positive nmosd, and mog antibody-associated disease

Bianchi, A ; Cortese, R ; Prados, F ; Tur, C ; Kanber, B ; Yiannakas, M ; De Angelis, F ; Magnollay, L ; Jacob, A ; Brownlee, W ; Trip, A ; Nicholas, R ; Hacohen, Y ; Barkhof, F ; Ciccarelli, O ; Toosy, A

8th joint ACTRIMS-ECTRIMS Virtual meeting 2020

Texto completo disponível

Citações Citado por
2
The role of attention in functional movement disorders
The role of attention in functional movement disorders
Material Type:
Imagem 		Adicionar ao Meu Espaço

The role of attention in functional movement disorders

Huys, A ; Haggard, P ; Bhatia, K ; Edwards, M

WILEY 2019

Texto completo disponível

Citações Citado por
3
Supplemental Material, sj-jpg-2-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Supplemental Material, sj-jpg-2-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Material, sj-jpg-2-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank

SAGE Journals 2022

Texto completo disponível

Citações Citado por
4
Supplemental Material, sj-jpg-1-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Supplemental Material, sj-jpg-1-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Material, sj-jpg-1-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank

SAGE Journals 2022

Texto completo disponível

Citações Citado por
5
Supplemental Material, sj-jpg-3-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Supplemental Material, sj-jpg-3-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Material, sj-jpg-3-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank

SAGE Journals 2022

Texto completo disponível

Citações Citado por
6
Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplemental Material, sj-jpg-4-rep-10.1177_25158163221131326 - Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies

Baker, Brian ; Shen, Vivienne ; Cady, Roger ; Ettrup, Anders ; Larsen, Frank

SAGE Journals 2022

Texto completo disponível

Citações Citado por
7
Supplementary Data.docx
Supplementary Data.docx
Material Type:
Imagem 		Adicionar ao Meu Espaço

Supplementary Data.docx

Urbi, Berzenn

figshare 2022

Texto completo disponível

Citações Citado por
8
sj-jpg-1-wso-10.1177_17474930241253482 – Supplemental material for Temporal association between atrial fibrillation and ischemic stroke: Systematic review and meta-analysis
sj-jpg-1-wso-10.1177_17474930241253482 – Supplemental material for Temporal association between atrial fibrillation and ischemic stroke: Systematic review and meta-analysis
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-jpg-1-wso-10.1177_17474930241253482 – Supplemental material for Temporal association between atrial fibrillation and ischemic stroke: Systematic review and meta-analysis

D’lima, Jessica ; Thijs, Vincent ; Lim, Han S ; Rodrigues, Thalys Sampaio ; Beaudoin, Ann-Marie

SAGE Journals 2024

Texto completo disponível

Citações Citado por
9
sj-ai-4-mso-10.1177_20552173241238632 - Supplemental material for Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program
sj-ai-4-mso-10.1177_20552173241238632 - Supplemental material for Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-ai-4-mso-10.1177_20552173241238632 - Supplemental material for Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program

Salvetti, Marco ; Wray, Sibyl ; Nelles, Gereon ; Belviso, Nicholas ; Kumar, Achint ; Koster, Thijs ; Castro-Borrero, Wanda ; Vignos, Megan

SAGE Journals 2024

Texto completo disponível

Citações Citado por
10
sj-tiff-3-eso-10.1177_23969873241253366 – Supplemental material for Artificial intelligence to predict individualized outcome of acute ischemic stroke patients: The SIBILLA project
sj-tiff-3-eso-10.1177_23969873241253366 – Supplemental material for Artificial intelligence to predict individualized outcome of acute ischemic stroke patients: The SIBILLA project
Material Type:
Imagem 		Adicionar ao Meu Espaço

sj-tiff-3-eso-10.1177_23969873241253366 – Supplemental material for Artificial intelligence to predict individualized outcome of acute ischemic stroke patients: The SIBILLA project

Caliandro, Pietro ; Lenkowicz, Jacopo ; Reale, Giuseppe ; Scaringi, Simone ; Zauli, Aurelia ; Uccheddu, Christian ; Fabiole-Nicoletto, Simone ; Patarnello, Stefano ; Damiani, Andrea ; Tagliaferri, Luca ; Valente, Iacopo ; Moci, Marco ; Monforte, Mauro ; Valentini, Vincenzo ; Calabresi, Paolo

SAGE Journals 2024

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2016  (2)
  2. 2016Até2017  (28)
  3. 2018Até2019  (241)
  4. 2020Até2022  (502)
  5. Após 2022  (167)
  6. Mais opções open sub menu

Base de Dados/Biblioteca 

  1. DataCite  (937)
  2. UCL Discovery  (2)
  3. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.